LYSVULPEN peroralna suspenzija za lisice
LYSVULPEN peroralna suspenzija za lisice
Authorised
- Rabies virus, strain SAD Bern, Live
Product identification
Medicine name:
LYSVULPEN peroralna suspenzija za lisice
Active substance:
- Rabies virus, strain SAD Bern, Live
Target species:
-
Fox
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Rabies virus, strain SAD Bern, Live180000000.00/log10 50% tissue culture infectious dose1.00Dose
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Fox
-
Not applicableno withdrawal periodNi smislelno.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07BD
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovenia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
- NP/V/0192/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 21/02/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 21/02/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 21/02/2025